Want to know more? Download the Free Info Guide

Want to know more? Download the Free Info Guide

Get Support: +971 (800) 2796Ar En

Stem Cell Uses
& Disease Treated

Cord blood is a rich source of newborn stem cells that has over the last 30 years been used in successful FDA-approved treatments for more than 80 serious diseases to replace damaged blood and immune systems with healthy cells.

Proven transplant
medicine uses:

  • Acute Biphenotypic Leukemia
  • Acute Lymphocytic Leukemia (ALL)
  • Acute Myelogenous Leukemia (AML)
  • Acute Undifferentiated Leukemia
  • Adult T Cell Leukemia/Lymphoma
  • Chronic Active Epstein Barr
  • Chronic Lymphocytic Leukemia (CLL)
  • Chronic Myelogenous Leukemia (CML)
  • Ewing Sarcoma
  • Hodgkin’s Lymphoma
  • Juvenile Chronic Myelogenous Leukemia (JCML)
  • Juvenile Myelomonocytic Leukemia (JMML)
  • Myeloid/Natural Killer (NK) Cell PrecursorAcute Leukemia
  • Non-Hodgkin’s Lymphoma
  • Prolymphocytic Leukemia
  • Plasma Cell Leukemia
  • Chronic Myelomonocytic Leukemia (CMML)
  • Leukocyte Adhesion Deficiency
  • Multiple Myeloma
  • Neuroblastoma
  • Rhabdomyosarcoma
  • Thymoma (Thymic Carcinoma)
  • Waldenstrom’s Macroglobulinemia
  • Wilms Tumor
  • Bare Lymphocyte Syndrome (SCID)
  • Chediak-Higashi Syndrome (SCID)
  • Chronic Granulomatous Disease
  • Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked (IPEX) Syndrome
  • Congenital Neutropenia
  • DiGeorge Syndrome
  • Evans Syndrome
  • Hemophagocytic Lymphohistiocytosis (HLH)
  • Fucosidosis
  • Kostmann Syndrome (SCID)
  • Hemophagocytosis Langerhans’ Cell Histiocytosis (Histiocytosis X)
  • Myelokathexis
  • Omenn Syndrome (SCID)
  • Phosphorylase Deficiency (SCID)
  • Purine Nucleoside (SCID)
  • Severe Combined Immunodeficiency Diseases (SCID)
  • Reticular Dysgenesis (SCID)
  • IKK Gamma Deficiency (NEMO Deficiency)
  • Thymic Dysplasia
  • Wiskott-Aldrich Syndrome
  • X-linked Agammaglobulinemia
  • X-Linked Hyper IgM Syndrome
  • Adenosine Deaminase Deficiency (SCID)
  • X-Linked Lymphoproliferative Disorder
  • Gaucher Disease
  • Hunter Syndrome (MPS-II)
  • Hurler Syndrome (MPS-IH)
  • Krabbe Disease
  • Neuronal Ceroid Lipofuscinosis (Batten Disease)
  • Lesch-Nyhan Syndrome
  • Mannosidosis
  • Maroteaux-Lamy Syndrome (MPS-VI)
  • Metachromatic Leukodystrophy
  • Mucolipidosis II (I-cell Disease)
  • Niemann-Pick Disease
  • Sandhoff Disease
  • Congenital Erythropoietic Porphyria (Gunther Disease)
  • Sanfilippo Syndrome (MPS-III)
  • Scheie Syndrome (MPS-IS)
  • Sly Syndrome (MPS-VII)
  • Tay Sachs
  • Wolman Disease
  • X-Linked Adrenoleukodystrophy
  • Acute Myelofibrosis
  • Amyloidosis
  • Congenital Amegakaryocytic Thrombocytopenia (CAT)
  • Aplastic Anemia (Severe)
  • Beta Thalassemia Major
  • Blackfan-Diamond Anemia
  • Congenital Cytopenia
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Dyskeratosis Congenita
  • Essential Thrombocythemia
  • Fanconi Anemia
  • Congenital Dyserythropoietic Anemia
  • Refractory Anemia with Excess Blasts in Transition (RAEB-T)
  • Glanzmann’s Thrombasthenia
  • Myelodysplastic Syndrome
  • Polycythemia Vera
  • Refractory Anemia with Ringed Sideroblasts (RARS)
  • Pure Red Cell Aplasia
  • Shwachman-Diamond Syndrome
  • Sickle Cell Disease
  • Agnogenic Myeloid Metaplasia

Regenerative Medicine

As cord blood stem cell research advances, so does the potential for future uses. Experimental therapies that may not have seemed possible 20 years ago are being explored today in FDA regulated clinical trials. Regenerative medicine is revolutionary field of medicine that aims to replace, repair, and regenerate human cells, tissues, or organs lost or injured due to age, disease, or congenital defects to restore or establish normal function in areas of research within regenerative medicine:

  • Autoimmune
  • Cardiovascular
  • Neurological (Acquired)
  • Tissue or organ damage
  • Orthopedic
  • Neurological (Degenerative)

The Transformative Power of Stem Cells

Each day, we learn more about stem cells and their role in regenerative medicine. Current studies and clinical trials are fueling research into new applications for the future, so the possibilities for your family are endless. These trials represent a new, exciting age in umbilical cord blood and tissue research. It’s estimated that 1 in 3 people will benefit from regenerative medicine in their lifetime.

Now is The Only Time

For over two decades, CellSave has worked with
hundreds of thousands of families to preserve their
newborn’s valuable stem cells through cord blood
and tissue banking. Take advantage of this once-in-a-lifetime opportunity and join the CellSave family today!

learn more